Veru Inc. (VERU) Financials

VERU

FY2025 annual

Revenue Not reported for FY2025

Net Income -$22.7M +39.9% YoY

Free Cash Flow -$30.0M -37.6% YoY

Operating Cash Flow -$30.0M -38.6% YoY

Market Cap $39.2M as of Oct 17, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 1.4x on $28.4M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 10, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VERU SEC filings page.

This page shows Veru Inc. (VERU) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VERU FY2025 2026-10-03

Veru has shifted from a profitable commercial business to a cash-consuming development operation with shrinking scale and continuing funding needs.

In FY2024, the net loss narrowed to $37.8M while operating cash flow improved to -$21.7M. By FY2025, the net loss narrowed further to $22.7M, but operating cash flow worsened to -$30.0M, showing that accounting improvement did not translate into better cash conversion.

Gross margin fell from 78.2% in FY2021 to 34.7% in FY2024, indicating the remaining sales mix was materially less profitable. In FY2023, R&D reached $51.2M against revenue of $16.3M, so development spending outweighed the commercial base.

FY2025 free cash flow was essentially the same as operating cash flow, while capital expenditures were only $1K; the cash drain therefore came from operations rather than heavy reinvestment. A 2.4x current ratio indicates short-term assets exceeded near-term obligations, while the reported liquidity measure equaled 6.3 months of the latest annual operating outflow.

Financial Health Signals

Financial health score not available

Veru Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/6

Veru Inc. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

Veru Inc. reported a net loss of $22.7M while operations used $30.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$7.7M

YoY-2.2%

QoQ-6.9%

Veru Inc.'s EBITDA was -$7.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.2% from the same quarter a year earlier. Against the prior quarter it is down 6.9%.

Net Income

-$7.0M

YoY+4.7%

QoQ-154.9%

Veru Inc. reported -$7.0M in net income in Q3 2026. This represents an increase of 4.7% from the same quarter a year earlier. Against the prior quarter it is down 154.9%.

Revenue

Not reported for Q3 2026.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

-$5.5M

YoY+0.3%

QoQ+38.7%

Veru Inc. recorded an outflow of $5.5M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents an increase of 0.3% from the same quarter a year earlier. Against the prior quarter it is up 38.7%.

Cash & Debt

$23.9M

YoY+59.1%

QoQ-13.5%

Veru Inc. held $23.9M in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding

17M

YoY+16.4%

QoQ+6.2%

5Y CAGR-26.6%

10Y CAGR-5.2%

Veru Inc. had 17M shares outstanding in Q3 2026. This represents an increase of 16.4% from the same quarter a year earlier. Against the prior quarter it is up 6.2%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity

-24.6%

YoY+23.2pp

QoQ-16.8pp

Veru Inc.'s ROE was -24.6% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 23.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.8 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Net Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending

$4.4M

YoY+44.1%

QoQ+38.4%

Veru Inc. invested $4.4M in research and development in Q3 2026. This represents an increase of 44.1% from the same quarter a year earlier. Against the prior quarter it is up 38.4%.

Capital Expenditures

Veru Inc. reported no capital expenditure in Q3 2026.

Share Buybacks

Not reported for Q3 2026.

VERU Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VERU quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	N/A	N/A	$16.9M+3.6%	$16.3M-58.6%	$39.4M-35.8%	$61.3M+43.8%	$42.6M+33.9%	$31.8M+100.5%	$15.9M+16.2%	$13.7M-38.3%	$22.1M-32.1%	$32.6M+33.1%	$24.5M-22.1%	$31.5M-10.2%	$35.0M+88.7%	$18.6M
Cost of Revenue	N/A	N/A	$11.0M+26.4%	$8.7M-0.4%	$8.8M-34.3%	$13.3M+12.9%	$11.8M+16.3%	$10.1M+43.1%	$7.1M+6.9%	$6.6M-24.4%	$8.8M-35.6%	$13.6M+19.9%	$11.4M-18.5%	$14.0M-3.2%	$14.4M+65.7%	$8.7M
Gross Profit	N/A	N/A	$5.9M-22.6%	$7.6M-75.3%	$30.6M-36.2%	$47.9M+55.7%	$30.8M+42.2%	$21.7M+146.9%	$8.8M+25.0%	$7.0M-47.4%	$13.3M-29.6%	$19.0M+44.6%	$13.1M-25.0%	$17.5M-15.1%	$20.6M+109.0%	$9.9M
R&D Expenses	N/A	$15.6M+22.0%	$12.8M-75.0%	$51.2M-27.8%	$70.9M+116.9%	$32.7M+93.1%	$16.9M+23.2%	$13.7M+26.7%	$10.9M+252.7%	$3.1M+2995.2%	$99K-54.8%	$220K+3842.9%	$6K+17.5%	$5K-10.1%	$5K-51.7%	$11K
SG&A Expenses	N/A	$19.9M-36.0%	$31.2M-35.1%	$48.1M+11.3%	$43.2M+108.9%	$20.7M+42.6%	$14.5M+1.0%	$14.3M-3.1%	$14.8M+28.7%	$11.5M+32.8%	$8.7M-28.6%	$12.1M+32.8%	$9.1M+22.0%	$7.5M-22.2%	$9.6M+47.3%	$6.5M
Operating Income	N/A	-$24.8M+31.6%	-$36.2M+61.4%	-$93.8M-12.3%	-$83.5M-743.6%	$13.0M+188.0%	-$14.7M-129.1%	-$6.4M+69.2%	-$20.9M-145.7%	-$8.5M-381.4%	$3.0M-54.4%	$6.6M+68.7%	$3.9M-59.9%	$9.8M-10.5%	$10.9M+232.0%	$3.3M
EBITDA	N/A	-$24.6M+31.5%	-$35.9M+61.6%	-$93.5M-12.3%	-$83.3M-731.2%	$13.2M+192.4%	-$14.3M	N/A	-$20.7M-153.6%	-$8.2M-337.1%	$3.4M-51.6%	$7.1M+57.6%	$4.5M-56.4%	$10.3M-9.3%	$11.4M+203.2%	$3.8M
Interest Expense	N/A	N/A	$607K-75.0%	$2.4M-44.4%	$4.4M-10.6%	$4.9M+5.7%	$4.6M-1.8%	$4.7M+59.5%	$3.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	$0	$0-100.0%	$480K+103.1%	$236K+107.6%	-$3.1M-190.2%	-$1.1M-254.8%	-$304K-135.1%	$866K+143.5%	-$2.0M-180.6%	$2.5M+5.5%	$2.3M+53.6%	$1.5M+134.6%	-$4.4M+2.2%	-$4.5M-108.0%	-$2.2M
Net Income	N/A	-$22.7M+39.9%	-$37.8M+59.4%	-$93.2M-10.8%	-$84.0M-1236.5%	$7.4M+139.0%	-$19.0M-57.9%	-$12.0M+49.8%	-$23.9M-262.0%	-$6.6M-2018.1%	$345K-92.1%	$4.3M+78.6%	$2.4M-83.0%	$14.3M-6.3%	$15.3M+183.4%	$5.4M
EPS (Basic)	N/A	-$1.55+44.6%	-$2.80-154.5%	-$1.10-4.8%	-$1.05-1150.0%	$0.10+135.7%	-$0.28	N/A	N/A	-$0.25-2600.0%	$0.01-93.3%	$0.15+66.7%	$0.09-82.4%	$0.51-7.3%	$0.55+175.0%	$0.20
EPS (Diluted)	—	N/A	N/A	-$1.10-4.8%	-$1.05-1266.7%	$0.09+132.1%	-$0.28	N/A	N/A	-$0.25-2600.0%	$0.01-93.3%	$0.15+87.5%	$0.08-84.0%	$0.50-5.7%	$0.53+178.9%	$0.19
Diluted Shares (Avg)	N/A	N/A	N/A	85M+6.1%	80M-4.4%	84M+25.5%	67M	N/A	N/A	35M+19.8%	29M0.0%	29M+0.2%	29M+0.5%	29M-0.7%	29M-0.1%	29M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	N/A	N/A	N/A	N/A	$0-100.0%	$0-100.0%	N/A	$6.7M+72.4%
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.0M+71.0%
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2.7M+74.4%
R&D Expenses	$4.4M+44.1%	$3.1M-20.0%	$1.3M-76.5%	N/A	$3.0M-37.7%	$3.9M+31.7%	$5.7M+244.7%	$3.3M-16.5%
SG&A Expenses	$3.4M-32.9%	$4.1M-21.1%	$4.1M-21.9%	N/A	$5.0M-13.8%	$5.2M-12.5%	$5.2M-21.4%	$12.8M+89.2%
Operating Income	-$7.7M-2.2%	-$7.2M+11.1%	-$5.4M+47.1%	N/A	-$7.5M+28.4%	-$8.1M+8.6%	-$10.2M-38.6%	-$9.3M-14.3%
EBITDA	-$7.7M-2.2%	-$7.2M+11.1%	-$5.4M+47.0%	N/A	-$7.5M+28.5%	-$8.1M+8.6%	-$10.2M-39.1%	-$9.2M-13.7%
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$170K-18.0%
Income Tax	$0	$0	$0	N/A	$0	$0	$0	$0-100.0%
Net Income	-$7.0M+4.7%	-$2.7M+65.3%	-$5.3M+40.4%	N/A	-$7.3M+33.1%	-$7.9M+21.2%	-$8.9M-8.1%	-$8.5M-4.9%
EPS (Basic)	-$0.30+40.0%	-$0.12+77.8%	-$0.26+57.4%	$0.10+117.5%	-$0.50+33.3%	-$0.54-671.4%	-$0.61-662.5%	-$0.57-612.5%

Not reported in any period shown, so not listed: EPS (Diluted), Diluted Shares (Avg).

VERU Balance Sheet

VERU quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$29.8M-50.6%	$60.4M+20.8%	$50.0M-63.0%	$135.4M-24.0%	$178.1M+245.6%	$51.5M-3.9%	$53.6M+10.7%	$48.5M-12.4%	$55.3M+43.3%	$38.6M+3.1%	$37.5M+18.3%	$31.7M-9.9%	$35.2M+15.5%	$30.4M+56.6%	$19.4M
Current Assets	$18.9M-46.3%	$35.2M+53.6%	$22.9M-77.9%	$104.0M-31.5%	$151.8M+461.7%	$27.0M+60.7%	$16.8M+50.3%	$11.2M+8.6%	$10.3M-36.8%	$16.3M-24.5%	$21.6M+65.1%	$13.1M-22.6%	$16.9M+0.4%	$16.8M+72.6%	$9.7M
Cash & Equivalents	$15.8M-36.6%	$24.9M+158.9%	$9.6M	N/A	N/A	N/A	N/A	$3.8M+14.7%	$3.3M+37.4%	$2.4M-41.9%	$4.1M-29.2%	$5.8M-35.0%	$8.9M+68.5%	$5.3M+24.5%	$4.3M
Short-Term Investments	$0	$0	$0	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	$4.1M-38.1%	$6.7M-22.3%	$8.6M+54.6%	$5.6M-16.9%	$6.7M+83.8%	$3.6M+58.4%	$2.3M-16.8%	$2.8M+11.0%	$2.5M+42.8%	$1.7M-41.5%	$3.0M+21.3%	$2.5M+68.7%	$1.5M-28.0%	$2.0M
Accounts Receivable	N/A	$4.0M-12.1%	$4.5M+26.9%	$3.6M-59.6%	$8.8M+68.2%	$5.2M+4.1%	$5.0M+26.4%	$4.0M+16.2%	$3.4M-68.3%	$10.8M-23.5%	$14.1M+378.6%	$2.9M+24.6%	$2.4M-67.5%	$7.3M+215.3%	$2.3M
Long-Term Investments	$0	$0	$0	N/A	N/A	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$11.5M-59.1%	$28.1M-7.4%	$30.3M-42.3%	$52.6M+103.3%	$25.9M+20.6%	$21.4M+0.6%	$21.3M+12.3%	$19.0M+175.6%	$6.9M+46.8%	$4.7M+8.1%	$4.3M+20.3%	$3.6M-4.2%	$3.8M-39.5%	$6.2M+131.5%	$2.7M
Current Liabilities	$7.8M-34.4%	$11.9M-33.4%	$17.8M-54.0%	$38.7M+145.5%	$15.8M+7.1%	$14.7M+5.0%	$14.0M+3.4%	$13.6M+147.0%	$5.5M+64.0%	$3.3M-20.8%	$4.2M+25.1%	$3.4M-2.5%	$3.5M-40.9%	$5.9M+155.5%	$2.3M
Non-Current Liabilities	$3.7M-77.1%	$16.2M+29.5%	$12.5M-9.5%	$13.8M+37.3%	$10.1M+50.4%	$6.7M-7.8%	$7.3M+34.3%	$5.4M+288.2%	$1.4M+3.9%	$1.3M+1082.5%	$114K-50.5%	$230K-24.0%	$302K-17.9%	$368K-7.3%	$397K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$18.3M-43.3%	$32.3M+64.2%	$19.7M-76.2%	$82.8M-46.4%	$154.5M+413.2%	$30.1M-6.9%	$32.3M+9.7%	$29.5M-39.2%	$48.5M+42.8%	$33.9M+2.4%	$33.1M+18.1%	$28.1M-10.6%	$31.4M+29.7%	$24.2M+44.6%	$16.8M
Retained Earnings	-$317.3M-7.7%	-$294.6M-14.7%	-$256.8M-56.9%	-$163.6M-100.0%	-$81.8M+8.3%	-$89.2M-27.0%	-$70.2M-20.6%	-$58.2M-69.9%	-$34.3M-23.9%	-$27.7M+1.2%	-$28.0M+13.4%	-$32.3M-12.6%	-$28.7M+19.3%	-$35.6M+20.4%	-$44.7M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$37.0M+35.5%	$43.1M+31.9%	$47.6M+19.4%	$29.8M-50.6%	$27.3M-57.7%	$32.7M-54.5%	$39.8M-50.6%	$60.4M+20.8%
Current Assets	$27.2M+68.1%	$33.4M+56.0%	$36.8M+29.7%	$18.9M-46.3%	$16.2M-57.9%	$21.4M-52.6%	$28.4M-46.8%	$35.2M+53.6%
Cash & Equivalents	$23.9M+59.1%	$27.6M+37.9%	$33.0M+24.0%	$15.8M-36.6%	$15.0M-48.5%	$20.0M	$26.6M	$24.9M+158.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.1M-38.1%
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$4.0M-12.1%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M0.0%	$6.9M-0.3%	$6.9M0.0%
Total Liabilities	$8.7M-27.8%	$8.3M-28.6%	$10.4M-20.9%	$11.5M-59.1%	$12.0M-55.6%	$11.6M-56.3%	$13.2M-54.4%	$28.1M-7.4%
Current Liabilities	$6.2M-7.9%	$5.4M-4.1%	$7.1M+12.3%	$7.8M-34.4%	$6.7M-37.1%	$5.6M-41.3%	$6.3M-61.8%	$11.9M-33.4%
Non-Current Liabilities	$2.5M-53.0%	$2.9M-51.6%	$3.3M-51.6%	$3.7M-77.1%	$5.3M-67.6%	$6.0M-64.7%	$6.9M-44.5%	$16.2M+29.5%
Total Equity	$28.4M+84.9%	$34.8M+65.3%	$37.1M+39.4%	$18.3M-43.3%	$15.3M-59.2%	$21.0M-53.4%	$26.6M-48.4%	$32.3M+64.2%
Retained Earnings	-$332.4M-4.3%	-$325.4M-4.5%	-$322.6M-6.3%	-$317.3M-7.7%	-$318.7M-11.4%	-$311.4M-13.2%	-$303.5M-14.5%	-$294.6M-14.7%

Not reported in any period shown, so not listed: Long-Term Debt.

VERU Cash Flow Statement

VERU quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$26.0M	-$30.0M-38.6%	-$21.7M+75.4%	-$88.0M-85.3%	-$47.5M-205.1%	-$15.6M-706.7%	-$1.9M+64.8%	-$5.5M+52.5%	-$11.5M-1274.7%	$983K+157.3%	-$1.7M-10.7%	-$1.5M-142.3%	$3.7M-68.9%	$11.8M+13.9%	$10.4M+48.6%	$7.0M
Depreciation & Amortization	N/A	$152K-43.3%	$268K-0.6%	$270K+26.9%	$213K-3.2%	$220K-53.3%	$471K	N/A	$177K-47.1%	$334K-21.0%	$423K-14.4%	$494K-16.1%	$589K+5.9%	$556K+20.6%	$461K-0.7%	$465K
Stock-Based Compensation	N/A	$8.1M-40.6%	$13.6M-23.9%	$17.9M+59.4%	$11.2M+122.6%	$5.1M+90.9%	$2.6M+38.8%	$1.9M+16.3%	$1.6M+116.7%	$756K+51.3%	$500K+2.1%	$490K-43.0%	$859K+18.0%	$728K-13.6%	$843K+5.8%	$796K
Capital Expenditures	$0	$1K-99.3%	$158K-76.2%	$666K-9.2%	$733K+94.6%	$377K+256.1%	$106K-2.5%	$109K+114.2%	$51K-62.1%	$133K+1994.2%	$6K-95.3%	$135K+39.2%	$97K-67.8%	$302K-57.9%	$718K+1451.8%	$46K
Free Cash Flow	-$26.0M	-$30.0M-37.6%	-$21.8M+75.4%	-$88.7M-83.8%	-$48.2M-202.5%	-$15.9M-683.3%	-$2.0M+63.6%	-$5.6M+51.8%	-$11.6M-1465.3%	$849K+149.4%	-$1.7M-2.2%	-$1.7M-147.2%	$3.6M-68.9%	$11.5M+19.2%	$9.6M+39.2%	$6.9M
Investing Cash Flow	$11.6M	$25.1M+17096.0%	$146K-97.7%	$6.3M+48.5%	$4.3M-70.8%	$14.6M+13926.9%	-$106K+2.5%	-$109K-114.2%	-$51K+43.9%	-$90K	N/A	N/A	N/A	-$302K+53.8%	-$654K-1313.3%	-$46K
Financing Cash Flow	$23.3M	-$4.2M-111.5%	$36.8M+231.3%	$11.1M+939.5%	$1.1M-99.0%	$109.7M+1076.0%	$9.3M+14.8%	$8.1M-32.7%	$12.1M	N/A	N/A	N/A	N/A	-$7.9M+9.2%	-$8.7M-54.9%	-$5.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5K-99.9%	$6.1M-18.7%	$7.5M+21.0%	$6.2M+12.7%	$5.5M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$950-99.9%	$738K+86.5%	$396K+36.6%	$290K+775.9%	$33K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$5.5M+0.3%	-$8.9M-15.2%	-$6.2M+45.6%	-$5.5M-25.8%	-$5.5M+2.9%	-$7.7M-36.9%	-$11.3M-88.2%	-$4.4M+54.0%
Depreciation & Amortization	$28K-3.4%	$28K-3.4%	$28K-56.5%	$29K-56.1%	$29K-9.4%	$29K-9.4%	$65K-10.1%	$65K-7.2%
Stock-Based Compensation	$578K-65.4%	$403K-81.9%	$758K-71.7%	N/A	$1.7M-50.6%	$2.2M-38.8%	$2.7M-21.5%	N/A
Capital Expenditures	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$1K	$63K-70.4%
Free Cash Flow	-$5.5M+0.3%	-$8.9M-15.2%	-$6.2M+45.6%	-$5.5M-24.0%	-$5.5M+3.8%	-$7.7M-35.9%	-$11.3M-88.3%	-$4.4M+54.4%
Investing Cash Flow	$1.8M+280.2%	$3.5M+206.7%	$0-100.0%	$6.3M+4672.4%	$474K+756.2%	$1.1M+2923.3%	$17.2M	$132K-83.3%
Financing Cash Flow	-$52K	$0	$23.4M+653.5%	$0	$0-100.0%	$0+100.0%	-$4.2M-111.4%	$0-100.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

VERU Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VERU quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	34.7%-11.8pp	46.4%-31.3pp	77.7%-0.5pp	78.2%+6.0pp	72.3%+4.2pp	68.1%+12.8pp	55.3%+3.9pp	51.4%-8.9pp	60.3%+2.1pp	58.2%+4.6pp	53.6%-2.1pp	55.6%-3.2pp	58.9%+5.7pp	53.1%
Operating Margin	N/A	-214.2%	-575.5%	-212.1%	21.2%+55.8pp	-34.6%-14.4pp	-20.2%	-131.6%	-62.2%-75.8pp	13.6%-6.7pp	20.3%+4.3pp	16.0%-15.1pp	31.1%-0.1pp	31.2%+13.5pp	17.8%
Net Margin	N/A	-223.9%	-571.6%	-213.5%	12.1%+56.6pp	-44.5%-6.8pp	-37.8%	-150.9%	-48.4%-50.0pp	1.6%-11.8pp	13.3%+3.4pp	9.9%-35.7pp	45.6%+1.9pp	43.7%+14.6pp	29.1%
Return on Equity	-124.0%-7.0pp	-117.0%+356.4pp	-473.4%-371.9pp	-101.5%-106.3pp	4.8%+67.8pp	-63.0%-25.8pp	-37.2%+44.0pp	-81.2%-67.5pp	-13.7%-14.7pp	1.0%-12.1pp	13.1%+4.5pp	8.7%-37.0pp	45.7%-17.5pp	63.2%+30.9pp	32.2%
Return on Assets	-76.2%-13.6pp	-62.6%+123.6pp	-186.2%-124.1pp	-62.1%-66.2pp	4.2%+41.0pp	-36.8%-14.4pp	-22.4%+27.0pp	-49.4%-37.5pp	-11.9%-12.8pp	0.9%-10.7pp	11.6%+3.9pp	7.7%-33.1pp	40.8%-9.5pp	50.2%+22.5pp	27.8%
Current Ratio	2.43-0.5x	2.97+1.7x	1.29-1.4x	2.69-6.9x	9.62+7.8x	1.83+0.6x	1.20+0.4x	0.83-1.1x	1.88-3.0x	4.87-0.2x	5.11+1.2x	3.87-1.0x	4.87+2.0x	2.87-1.4x	4.25
Debt-to-Equity	0.63-0.2x	0.87-0.7x	1.54+0.9x	0.63+0.5x	0.17-0.5x	0.71+0.1x	0.66+0.6x	0.06-0.1x	0.140.0x	0.140.0x	0.130.0x	0.130.0x	0.12-0.1x	0.26+0.1x	0.16
Asset Turnover	N/A	0.280.0x	0.330.0x	0.29-0.1x	0.34-0.5x	0.83+0.2x	0.59+0.3x	0.33+0.1x	0.25-0.3x	0.57-0.3x	0.87+0.1x	0.77-0.1x	0.89-0.3x	1.15+0.2x	0.95
FCF Margin	N/A	-129.3%	-544.1%	-122.6%	-26.0%-21.2pp	-4.8%+12.8pp	-17.6%+55.5pp	-73.1%-79.3pp	6.2%+14.0pp	-7.8%-2.6pp	-5.2%-19.7pp	14.6%-22.0pp	36.5%+9.0pp	27.5%-9.8pp	37.3%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	40.4%+0.5pp
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-140.4%
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-128.2%
Return on Equity	-24.6%+23.2pp	-7.9%+29.7pp	-14.4%+19.2pp	N/A	-47.8%-18.6pp	-37.5%-15.4pp	-33.6%-17.6pp	-26.4%+14.9pp
Return on Assets	-18.9%+8.0pp	-6.4%+17.8pp	-11.2%+11.2pp	N/A	-26.8%-9.9pp	-24.2%-10.2pp	-22.5%-12.2pp	-14.1%+2.1pp
Current Ratio	4.42+2.0x	6.19+2.4x	5.16+0.7x	2.43-0.5x	2.42-1.2x	3.80-0.9x	4.47+1.3x	2.97+1.7x
Debt-to-Equity	0.30-0.5x	0.24-0.3x	0.28-0.2x	0.63-0.2x	0.78+0.1x	0.550.0x	0.50-0.1x	0.87-0.7x
Asset Turnover	N/A	N/A	N/A	N/A	0.00-0.1x	0.00-0.1x	N/A	0.110.0x
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-66.5%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Veru Inc. VERU	FY2025	N/A	-$22.7M	N/A	$39.2M	—
PolyPid Ltd. PYPD	FY2025	N/A	-$34.2M	N/A	$95.9M	—
BioXcel Therapeutics, Inc. BTAI	FY2025	$642K	-$69.9M	N/A	$2.3M	—
vTv Therapeutics Inc. VTVT	FY2025	$0	-$27.0M	N/A	$104.9M	—
Actinium Pharmaceuticals, Inc ATNM	FY2025	$90K	-$33.9M	N/A	$35.5M	—
Relmada Therapeutics, Inc. RLMD	FY2025	N/A	$0	N/A	$330.7M	—

Where Veru Inc. Ranks

Frequently Asked Questions

Is Veru Inc. profitable?

No, Veru Inc. (VERU) reported a net income of -$22.7M in fiscal year 2025.

What is Veru Inc.'s EBITDA?

Veru Inc. (VERU) had EBITDA of -$24.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Veru Inc.'s return on equity (ROE)?

Veru Inc. (VERU) has a return on equity of -124.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Veru Inc.'s free cash flow?

Veru Inc. (VERU) recorded an outflow of $30.0M in free cash flow during fiscal year 2025. This represents a -37.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Veru Inc.'s operating cash flow?

Veru Inc. (VERU) recorded an outflow of $30.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Veru Inc.'s total assets?

Veru Inc. (VERU) had $29.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Veru Inc.'s capital expenditures?

Veru Inc. (VERU) invested $1K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Veru Inc. spend on research and development?

Veru Inc. (VERU) invested $15.6M in research and development during fiscal year 2025.

How many shares does Veru Inc. have outstanding?

Veru Inc. (VERU) had 16M shares outstanding as of fiscal year 2025.

What is Veru Inc.'s current ratio?

Veru Inc. (VERU) had a current ratio of 2.43 as of fiscal year 2025, which is generally considered healthy.

What is Veru Inc.'s debt-to-equity ratio?

Veru Inc. (VERU) had a debt-to-equity ratio of 0.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Veru Inc.'s return on assets (ROA)?

Veru Inc. (VERU) had a return on assets of -76.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Veru Inc.'s P/E ratio?

Veru Inc. (VERU) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $39.2M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Veru Inc.'s price-to-sales ratio?

Veru Inc. (VERU) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $39.2M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Veru Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Veru Inc. (VERU) held $15.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $30.0M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Veru Inc.'s Piotroski F-Score?

Veru Inc. (VERU) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Veru Inc.'s earnings high quality?

Veru Inc. (VERU) reported a net loss of $22.7M while operations used $30.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.